Skip to search formSkip to main contentSkip to account menu

BRONCHODILATORS,ANTICHOLINERGIC

Known as: anticholinergic bronchodilators, anticholinergic bronchodilator, Bronchodilators, Anticholinergic 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (4)

30 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder Inhaler60 ACTUAT aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler60 ACTUAT tiotropium 0.00125 MG/ACTUAT Metered Dose Inhalertiotropium 0.018 MG Inhalant Powder
Asthma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Population Pharmacokinetics of Inhaled Umeclidinium and Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
Background and objectivesA fixed-dose combination of the bronchodilators umeclidinium and vilanterol is in development for the… 
2003
2003
Prescribing and administration of nebulized bronchodilators: A prospective audit in a university hospital
Objective:  Inaccurate and incomplete prescribing of nebulized bronchodilators can result in uncertainty and suboptimal treatment… 
1998
1998
Superoxide radical scavenging by phenolic bronchodilators under aprotic and aqueous conditions.
1996
1996
An investigation into perihilar inflammatory change on the chest radiographs of children admitted with acute respiratory symptoms.
1995
1995
Cost Comparison of β2‐Agonist Bronchodilators Used in the Treatment of Asthma
Because of increases in the morbidity and mortality associated with asthma, coupled with shrinking health care resources, the… 
1989
1989
Prescribing of nebulized bronchodilators--can we change bad habits?
Review
1985
Review
1985
The management of acute severe asthma.
A recent long-term prospective study has shown that the actual mortality of asthmatics outweighs the expected mortality… 
1972
1972
Nebulized bronchodilators in obstructive lung disease. I.
1972
1972
Nebulized bronchodilators in obstructive lung disease. II.
1955
1955
Diseases of the ChestThe Treatment of Pulmonary Emphysema and of Diffuse Pulmonary Fibrosis with Nebulized Bronchodilators and Intermittent Positive Pressure Breathing
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)